RecruitingNot ApplicableNCT06768827

New Mechanisms of Obesity

Pathogenic Mechanisms of Obesity and Its Cardiometabolic Complications


Sponsor

Yale University

Enrollment

55 participants

Start Date

Nov 13, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Given the pervasiveness of Pediatric Obesity, it is imperative to understand its pathophysiology and develop alternative strategies to reverse this condition. Herein, investigators propose to elucidate the interaction between colonic fermentation and insulin resistance in modulating metabolism in youth with obesity.


Eligibility

Min Age: 15 YearsMax Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Lactulose Oral Product for people with insulin resistance, obesity and obesity-related medical conditions, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 15 Years to 22 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERLactulose Oral Product

Each arm will undergo a study to induce colonic fermentation through lactulose at the beginning and at the end of the 12 weeks.


Locations(1)

Yale University

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06768827


Related Trials